How GLP-1 drugs change consumer behavior

While blockbuster drug innovations have changed health outcomes for decades, we’re now seeing signs that GLP-1 drugs like Ozempic and Wegovy may be changing something broader: the consumer economy. Originally developed to treat diabetes and increasingly prescribed for weight loss, these medications affect not only physical health and body size. It is also reshaping collective behavior – how people eat, shop, move, see themselves, and make decisions – with major implications for business leaders.